Zynex ROE 2010-2024 | ZYXI

Current and historical return on equity (ROE) values for Zynex (ZYXI) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Zynex ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-06-30 $0.01B $0.03B 14.04%
2024-03-31 $0.01B $0.03B 16.00%
2023-12-31 $0.01B $0.05B 17.32%
2023-09-30 $0.02B $0.06B 25.50%
2023-06-30 $0.02B $0.06B 26.46%
2023-03-31 $0.02B $0.06B 25.76%
2022-12-31 $0.02B $0.07B 23.19%
2022-09-30 $0.02B $0.07B 25.35%
2022-06-30 $0.02B $0.07B 26.95%
2022-03-31 $0.02B $0.08B 28.15%
2021-12-31 $0.02B $0.07B 27.20%
2021-09-30 $0.01B $0.06B 17.17%
2021-06-30 $0.01B $0.06B 8.93%
2021-03-31 $0.01B $0.06B 10.31%
2020-12-31 $0.01B $0.06B 22.36%
2020-09-30 $0.01B $0.05B 32.26%
2020-06-30 $0.01B $0.03B 51.16%
2020-03-31 $0.01B $0.02B 54.79%
2019-12-31 $0.01B $0.02B 58.06%
2019-09-30 $0.01B $0.02B 70.59%
2019-06-30 $0.01B $0.01B 90.91%
2019-03-31 $0.01B $0.01B 105.26%
2018-12-31 $0.01B $0.01B 129.03%
2018-09-30 $0.01B $0.01B 148.15%
2018-06-30 $0.01B $0.01B 180.00%
2018-03-31 $0.01B $0.01B 360.00%
2017-12-31 $0.01B $0.01B 1400.00%
2017-09-30 $0.00B $0.00B -228.57%
2017-06-30 $0.00B $-0.00B -92.31%
2017-03-31 $0.00B $-0.00B -25.00%
2016-12-31 $0.00B $-0.00B -23.53%
2016-09-30 $0.00B $-0.00B 0.00%
2016-06-30 $-0.00B $-0.01B 25.00%
2016-03-31 $-0.00B $-0.00B 28.57%
2015-12-31 $-0.00B $-0.00B 66.67%
2015-09-30 $0.00B $-0.00B 0.00%
2015-06-30 $0.00B $-0.00B 0.00%
2015-03-31 $-0.01B $-0.00B 342.86%
2014-12-31 $-0.01B $-0.00B 1200.00%
2014-09-30 $-0.01B $-0.00B -1200.00%
2014-06-30 $-0.01B $-0.00B -346.67%
2014-03-31 $-0.01B $0.00B -133.33%
2013-12-31 $-0.01B $0.01B -88.89%
2013-09-30 $-0.00B $0.01B -27.91%
2013-06-30 $-0.00B $0.01B -17.39%
2013-03-31 $0.00B $0.01B 0.00%
2012-12-31 $0.00B $0.01B 0.00%
2012-09-30 $0.00B $0.01B 9.09%
2012-06-30 $0.00B $0.01B 19.51%
2012-03-31 $0.00B $0.01B 20.51%
2011-12-31 $0.00B $0.01B 22.22%
2011-09-30 $0.00B $0.01B 11.76%
2011-06-30 $0.00B $0.01B 0.00%
2011-03-31 $0.00B $0.01B 0.00%
2010-12-31 $0.00B $0.01B 0.00%
2010-09-30 $0.00B $0.01B 0.00%
2010-06-30 $0.00B $0.01B 0.00%
2010-03-31 $0.00B $0.01B 14.81%
2009-12-31 $0.00B $0.01B 32.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.257B $0.184B
Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and spinal cord injury rehabilitation. The company's product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex markets its products through commissioned and independent sales representatives, as well as directly to end users through advertisements and articles in relevant publications and on the Internet. The company is headquartered in Littleton, Colorado.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $195.617B 25.27
Stryker (SYK) United States $137.290B 32.08
Boston Scientific (BSX) United States $122.743B 37.38
Medtronic (MDT) Ireland $114.552B 17.05
EssilorLuxottica (ESLOY) France $108.842B 0.00
Haleon (HLN) United Kingdom $48.651B 35.57
Lonza Group Ag (LZAGY) Switzerland $46.030B 0.00
ResMed (RMD) United States $35.117B 30.92
Koninklijke Philips (PHG) Netherlands $30.774B 23.39
Terumo (TRUMY) Japan $28.517B 40.27
Zimmer Biomet Holdings (ZBH) United States $22.039B 13.87
Baxter (BAX) United States $19.851B 13.46
Insulet (PODD) United States $16.269B 68.45
Smith & Nephew SNATS (SNN) United Kingdom $13.605B 0.00
Bio-Rad Laboratories (BIO) United States $9.247B 30.63
Demant (WILYY) Denmark $8.667B 0.00
BellRing Brands (BRBR) United States $7.898B 33.39
Lantheus Holdings (LNTH) United States $7.454B 17.89
ICU Medical (ICUI) United States $4.261B 40.67
Haemonetics (HAE) United States $4.084B 20.20
TG Therapeutics (TGTX) United States $3.689B 39.07
Neogen (NEOG) United States $3.599B 37.75
Prestige Consumer Healthcare (PBH) United States $3.534B 17.61
GN Store Nord (GNNDY) Denmark $3.509B 21.14
Perrigo (PRGO) Ireland $3.499B 11.06
Envista Holdings (NVST) United States $3.398B 18.13
QuidelOrtho (QDEL) United States $3.063B 19.30
Agios Pharmaceuticals (AGIO) United States $2.595B 0.00
Green Thumb Industries (GTBIF) United States $2.226B 37.36
Maravai LifeSciences Holdings (MRVI) United States $2.124B 0.00
LeMaitre Vascular (LMAT) United States $2.061B 54.92
Warby Parker (WRBY) United States $1.614B 0.00
AdaptHealth (AHCO) United States $1.497B 10.81
InMode (INMD) Israel $1.464B 9.32
AtriCure (ATRC) United States $1.372B 0.00
Owens & Minor (OMI) United States $1.247B 9.63
Verano Holdings (VRNOF) United States $1.184B 0.00
BioLife Solutions (BLFS) United States $1.123B 0.00
Evolus (EOLS) United States $1.006B 0.00
PetIQ (PETQ) United States $0.919B 23.30
Phibro Animal Health (PAHC) United States $0.894B 18.55
National Vision Holdings (EYE) United States $0.867B 27.55
Cresco Labs (CRLBF) United States $0.805B 0.00
Surmodics (SRDX) United States $0.549B 116.64
Quanterix (QTRX) United States $0.489B 0.00
VAREX IMAGING (VREX) United States $0.488B 14.72
Jin Medical (ZJYL) China $0.439B 0.00
ZimVie (ZIMV) United States $0.435B 40.41
Valneva SE (VALN) France $0.432B 0.00
Canopy Growth (CGC) Canada $0.402B 0.00
TerrAscend (TSNDF) Canada $0.389B 0.00
Cerus (CERS) United States $0.324B 0.00
Capricor Therapeutics (CAPR) United States $0.324B 0.00
OraSure Technologies (OSUR) United States $0.320B 8.25
Aurora Cannabis (ACB) Canada $0.319B 0.00
Biote (BTMD) United States $0.307B 14.18
Viemed Healthcare (VMD) United States $0.283B 30.38
Sanara MedTech (SMTI) United States $0.264B 0.00
Utah Medical Products (UTMD) United States $0.232B 15.41
Omeros (OMER) United States $0.227B 0.00
MacroGenics (MGNX) United States $0.200B 0.00
Ayr Wellness (AYRWF) United States $0.194B 0.00
Organigram Holdings (OGI) Canada $0.191B 0.00
High Tide (HITI) Canada $0.163B 67.33
FitLife Brands (FTLF) United States $0.153B 20.64
Brainsway (BWAY) Israel $0.135B 161.40
TriSalus Life Sciences (TLSI) United States $0.130B 0.00
Quipt Home Medical (QIPT) United States $0.121B 0.00
Rockwell Medical (RMTI) United States $0.114B 0.00
Veru (VERU) United States $0.113B 0.00
Fonar (FONR) United States $0.111B 11.44
Jushi Holdings (JUSHF) United States $0.104B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.101B 24.80
InterCure (INCR) Israel $0.087B 14.62
Zevia PBC (ZVIA) United States $0.083B 0.00
Cytosorbents (CTSO) United States $0.082B 0.00
Modular Medical (MODD) United States $0.074B 0.00
Cellectar Biosciences (CLRB) United States $0.073B 0.00
Safety Shot (SHOT) United States $0.071B 0.00
MariMed (MRMD) United States $0.065B 0.00
Exagen (XGN) United States $0.055B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.051B 3.35
Apyx Medical (APYX) United States $0.042B 0.00
Allurion Technologies (ALUR) United States $0.040B 0.00
ImmuCell (ICCC) United States $0.028B 0.00
Meihua Medical Technologies (MHUA) China $0.026B 0.00
Nephros (NEPH) United States $0.018B 0.00
Flora Growth (FLGC) United States $0.018B 0.00
Innovative Eyewear (LUCY) United States $0.014B 0.00
GlucoTrack (GCTK) United States $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.008B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
GUARDION HEALTH (GHSI) United States $0.007B 0.00
Agape ATP (ATPC) $0.007B 0.00
Leafly Holdings (LFLY) United States $0.006B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
Senestech (SNES) United States $0.001B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
Akanda (AKAN) United Kingdom $0.000B 0.00
United-Guardian (UG) United States $0.000B 21.30
SNDL (SNDL) Canada $0.000B 0.00